No Early Relief for JW Therapeutics from Cancer Wonder Drug “抗癌神药”营收有限 药明巨诺亏损扩大
The biotech company logs revenue of 66 million yuan from its cutting-edge cancer therapy, but losses jump more than 50% to nearly 430 million yuan 这家生物科技公司旗下的“抗癌神药”去年仅录得6,600万元收入，亏损额增加一半至4.3亿元。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.